★ America V2AuditLine ALPHA

AuditLine › HHS OIG › Centers for Medicare and Medicaid Services

HHS OIG recommendation 17-A-09-188.04

We recommend that the State agency work with CMS to determine whether the other physician-administered drugs, associated with 122,436 claim lines,…

Closed ImplementedThe publisher's status, as reported by HHS Office of Inspector General in the file read .

The recommendation, in the publisher's words

We recommend that the State agency work with CMS to determine whether the other physician-administered drugs, associated with 122,436 claim lines, were eligible for rebates and, if so, determine the rebates due and upon receipt of the rebates refund the Federal share of the rebates collected.
Responsible agency
Centers for Medicare and Medicaid Services
Issued
September 26, 2017
Report
Hawaii Did Not Bill Manufacturers for Some Rebates for Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations (A-09-16-02029) · find it at HHS OIG
Kind of report
Audit
Agency response
Concur (as recorded by the publisher)
Closed
November 23, 2022 (publisher's date)
Publisher topics
Managed Care, Prescription Drug

“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.

Dated history

  1. Issued by HHS OIG. (publisher's date)
  2. Closed, with status “Closed Implemented”. (publisher's date)
  3. First recorded by AuditLine. (start of AuditLine's own history for this record)

Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.

Other recommendations from this report

4 more, of which 0 are open in the publisher's file.

Source

Open this report in HHS OIG's tracker This publisher's records (CSV)

Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows, SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.